NCT02483130View on ClinicalTrials.gov

Effect of N-acetylcysteine on Brain Glutamate

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Psychosis
Interventions
DIETARY_SUPPLEMENT

N-Acetylcysteine

Participants will receive 2400mg of N-Acetylcysteine orally via 6 x 400mg capsules.

OTHER

Placebo

Participants will receive 2400mg of placebo orally via 6 x 400mg capsules.

Trial Locations (1)

SE5 8AF

Institute of Psychiatry, Psychology and Neuroscience, Denmark Hill

All Listed Sponsors
lead

King's College London

OTHER

NCT02483130 - Effect of N-acetylcysteine on Brain Glutamate | Biotech Hunter | Biotech Hunter